Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

FCX

Analyzing Freeport-McMoRan (FCX) Through an Investor's Lens

Now trading at a price of $43.19, Freeport-McMoRan has moved -1.3% so far today.

Over the last year, Freeport-McMoRan logged a -0.1% change, with its stock price reaching a high of $52.61 and a low of $27.66. Over the same period, the stock underperformed the S&P 500 index by -17.7%. AThe company's 50-day average price was $42.31. Freeport-McMoRan Inc. engages in the mining of mineral properties in North America, South America, and Indonesia. Based in Phoenix, AZ, the Large-Cap Basic Materials company has 28,500 full time employees. Freeport-McMoRan has offered a 1.4% dividend yield over the last 12 months.

Strong Revenue Growth and Healthy Leverage Levels:

2019 2020 2021 2022 2023 2024
Revenue (M) $14,402 $14,198 $22,845 $22,780 $22,855 $25,455
Operating Margins 8% 17% 37% 31% 27% 27%
Net Margins -1% 6% 23% 20% 16% 17%
Net Income (M) -$189 $865 $5,365 $4,479 $3,751 $4,399
Net Interest Expense (M) -$620 -$598 -$602 -$560 -$515 -$319
Depreciation & Amort. (M) $1,412 $1,528 $1,998 $2,019 $2,068 $2,241
Diluted Shares (M) 1,457 1,461 1,482 1,451 1,443 1,445
Earnings Per Share -$0.17 $0.41 $2.9 $2.39 $1.28 $1.3
EPS Growth n/a 341.18% 607.32% -17.59% -46.44% 1.56%
Avg. Price $10.84 $13.42 $35.42 $40.96 $37.38 $43.79
P/E Ratio -63.76 32.73 12.09 17.14 29.2 33.68
Free Cash Flow (M) -$1,170 $1,056 $5,600 $1,670 $455 $2,352
CAPEX (M) $2,652 $1,961 $2,115 $3,469 $4,824 $4,808
EV / EBITDA 13.32 8.88 5.99 7.91 8.05 8.43
Total Debt (M) $19,647 $19,388 $18,528 $20,203 $18,078 $17,855
Net Debt / EBITDA 7.04 3.97 1.01 1.33 1.61 1.53
Current Ratio 2.47 2.72 2.52 2.46 2.42 2.42

Freeport-McMoRan has rapidly growing revenues and increasing reinvestment in the business, strong operating margins with a positive growth rate, and exceptional EPS growth. The company also benefits from generally positive cash flows, an excellent current ratio of 2.42, and healthy leverage levels.

Freeport-McMoRan's Valuation Is in Line With Its Sector Averages:

Freeport-McMoRan has a trailing twelve month P/E ratio of 32.1, compared to an average of 20.25 for the Basic Materials sector. Based on its EPS guidance of $2.16, the company has a forward P/E ratio of 19.6. According to the 45.4% compound average growth rate of Freeport-McMoRan's historical and projected earnings per share, the company's PEG ratio is 0.71. Taking the weighted average of the company's EPS CAGR and the broader market's 5-year projected EPS growth rate, we obtain a normalized growth rate of 20.3%. On this basis, the company's PEG ratio is 1.58. This suggests that these shares are overvalued. Furthermore, Freeport-McMoRan is likely overvalued compared to the book value of its equity, since its P/B ratio of 3.32 is higher than the sector average of 2.31. The company's shares are currently trading 129.0% below their Graham number.

Freeport-McMoRan Has an Average Rating of Buy:

The 18 analysts following Freeport-McMoRan have set target prices ranging from $27.0 to $57.0 per share, for an average of $50.89 with a buy rating. The company is trading -15.1% away from its average target price, indicating that there is an analyst consensus of some upside potential.

Freeport-McMoRan has a very low short interest because 1.8% of the company's shares are sold short. Institutions own 86.8% of the company's shares, and the insider ownership rate stands at 0.67%, suggesting a small amount of insider investors. The largest shareholder is Vanguard Group Inc, whose 9% stake in the company is worth $5,399,951,249.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS